A method for regulating macrophage polarization based on autophagy-exocrine pathway and its use

By regulating macrophage polarization with compounds that inhibit autophagy and exocrine behavior, the problem of excessive inflammatory response in influenza virus infection was solved, and effective control of influenza virus was achieved.

CN113667711BActive Publication Date: 2024-11-05FUDAN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202010409362.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-05-14
Publication Date
2024-11-05
Estimated Expiration
2040-05-14

AI Technical Summary

Technical Problem

Current technologies have not been able to effectively regulate macrophage polarization during influenza virus infection, leading to an excessive inflammatory response that makes it difficult to control viral replication and acute pneumonia.

Method used

Compounds that inhibit autophagy and exosome behavior, including PI3K inhibitors and exosome inhibitors, regulate macrophage polarization, blocking M1 polarization and recruitment.

Benefits of technology

Effectively inhibiting the excessive recruitment and polarization of macrophages caused by influenza virus infection and reducing the inflammatory response provides a basis for the preparation of anti-influenza virus drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0002492591550000011
    Figure HDA0002492591550000011
  • Figure HDA0002492591550000012
    Figure HDA0002492591550000012
  • Figure HDA0002492591550000021
    Figure HDA0002492591550000021
Patent Text Reader

Abstract

The present invention belongs to the field of biomedicine technology, and relates to a method for regulating macrophage polarization, and specifically to a method for regulating macrophage polarization based on the autophagy-exocrine pathway and its use. The method of the present invention regulates macrophage polarization by a compound that inhibits cell autophagy and cell exocrine behavior. It has been confirmed by experiments that macrophage M1 autophagy and recruitment can be regulated by blocking the cell autophagy-exocrine pathway, and excessive M1 activation and recruitment of macrophages induced by influenza virus can be antagonized, thereby inhibiting influenza virus infection. Furthermore, the compound that inhibits cell autophagy and cell exocrine behavior of the present method can be used to prepare a drug for treating influenza virus infection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of biomedicine and relates to a method for regulating macrophage polarization, and specifically relates to a method for regulating macrophage polarization based on an autophagy-exocrine pathway and a use thereof. The method of the present invention regulates the polarization function of macrophages through a variety of cell autophagy inhibitors and exosome inhibitors, and is further used to prepare drugs for treating influenza virus infection. Background Art

[0002] The prior art discloses that influenza virus belongs to the genus Orthomyxovirus, and is an enveloped virus containing eight negative-sense single-stranded RNAs (ssRNAs), which are tightly wrapped around the nucleoprotein to form the genome of the influenza virus. Studies have shown that influenza viruses have glycoproteins attached to their surface, such as hemagglutinin (HA) and neuraminidase (NA). Depending on the differences in HA and NA, influenza viruses are divided into different subtypes [1]. It is reported that influenza viruses cause frequent seasonal epidemics and unpredictable virus mutations leading to influenza pandemics. According to the World Health Organization (WHO), influenza viruses infect 1 billion people each year, with 3-5 million severe cases and 300,000-500,000 deaths [2]. At irregular intervals, viruses from animal hosts often cross the species barrier and undergo a gene segment recombination step between avian influenza virus and human influenza virus, resulting in antigenic recombination and the production of new influenza virus strains, causing influenza virus pandemics [3]. The morbidity and mortality associated with such new influenza virus pandemics far exceed those of seasonal influenza viruses. For example, the H1N1 influenza virus pandemic in 1918 conservatively estimated to have caused approximately 40 million deaths [4].

[0003] Studies have shown that influenza virus infection can recruit immune and non-immune cells in the respiratory tract to the site of infection[5], causing a series of inflammatory responses, inducing the generation of cytokine storms, leading to viral pneumonia, and increasing mortality[6]; the most serious of these is acute lung injury (ALI), accompanied by pulmonary edema, inflammatory cell infiltration, and pulmonary immune imbalance. In clinical practice, there are mainly two types of anti-influenza virus drugs: M2 ion channel inhibitors, such as adamantane; and neuraminidase inhibitors, such as oseltamivir. These drugs cannot improve the immune over-stress problems such as viral pneumonia induced by influenza virus infection, which is also the reason for the high mortality rate of influenza. At the same time, these antiviral drugs also face the problem of influenza virus mutation and drug resistance.

[0004] As one of the body's innate immune cells, macrophages play an important role in physiological and pathological conditions. The function of macrophages needs to be adjusted according to the tissue in which they are located. This adaptation is driven by both tissue and environmental factors. For example, Kupffer cells in the liver, osteoclasts in the bones, and alveolar macrophages in the lungs have different functions and phenotypes[7]. Macrophages are divided into two categories according to their polarization functions: classically activated M1 macrophages (pro-inflammatory) and alternatively activated M2 macrophages (anti-inflammatory)[8]. M1 polarized macrophages secrete pro-inflammatory cytokines, which have antibacterial and antiviral effects. Excessive secretion of inflammatory cytokines can cause tissue damage. M2 polarized macrophages secrete anti-inflammatory factors, which play an important role in tissue repair and tumorigenesis. Studies have shown that the transformation of macrophage function plays an important role in the different stages of progression of different diseases.

[0005] For influenza virus infection, macrophages are both a member of the innate immune cells and a host cell for viral infection and replication[9], so the role of macrophages is more complex. It has been reported that after influenza A virus infection, the application of high-dose GM-CSF reduces the high mortality rate after viral infection by regulating the polarization of pro-inflammatory M1 macrophages

[10] .

[0006] Autophagy is a conservative intracellular digestion process that degrades damaged organelles or proteins in eukaryotic cells

[11] . Damaged organelles or misfolded proteins are enclosed in a double membrane structure called an autophagosome, which then fuses with the lysosome. Its function is to act as a waste disposal system to remove potentially toxic cellular products, with the goal of degrading aggregated proteins and dysfunctional organelles. The degradation products are then released for cellular recycling

[12] , and small molecules that enter the cytoplasm are used as raw materials for synthesizing other substances or providing energy for cell operation

[13] . In this process, autophagy plays an important role in maintaining the balance of the intracellular environment by mediating the degradation of cellular macromolecules and dysfunctional organelles and the regeneration of nutrients required for cell growth. In addition, autophagy also plays an important role in innate

[14] and adaptive immunity

[15] . Hepatitis C virus (HCV) is a key player in the immune system. HCV) utilizes autophagy to replicate itself and weaken the body's innate immunity

[16] . Similarly, this phenomenon also exists in influenza A virus infection. Influenza virus induces the formation of autophagosomes, but blocks the fusion of autophagosomes and lysosomes through matrix ion channel protein 2 (Matrix 2, M2). Therefore, the virus replicates viral components through multifunctional autophagosomes[1]. Autophagy is also closely related to inflammation. Studies have shown that autophagy is a negative regulator of inflammasomes. Autophagy proteins, such as Atg7, LC3B or Beclin 1, or the administration of autophagy inhibitors wortmannin, 3-MA can enhance the production of IL-1β or IL-18 in macrophages

[17] . The effect of autophagy on the functional polarization of macrophages has also been studied in fields such as cancer treatment

[18] . In neurodegenerative diseases, the inhibition of autophagy can enhance the M1 polarization of macrophages, leading to neuroinflammation

[19] .

[0007] Exosomes are nanoscale vesicles that are released into the extracellular space after multivesicular bodies (MVBs) fuse with the cell membrane. Exosomes contain functional proteins, lipids, and RNA, and have been shown to play important roles in both physiology and pathology

[20] . Exosomes regulate cellular homeostasis, promote extensive phenotypic changes in recipient cells, regulate immune responses, cell migration, and cancer metastasis. Their production and selective rapid release of internal compounds give cells the ability to resist changes in protein, lipid, or RNA homeostasis under stress or pathological conditions

[21] . In addition, exosomes play an important role in cellular signaling. Exosomes regulate cellular autophagy by secreting microRNAs

[22] . Exosomes promote viral infection

[23] and exert antiviral immune responses

[24] . Cellular autophagy can also regulate exosomes. For example, in tumors, autophagy-related genes regulate the production of exosomes and promote tumor metastasis

[25] . Other studies have shown that the autophagy protein LC3 may be involved in the viral envelope and exocytosis process

[26] .

[0008] To date, there have been no reports on regulating influenza virus-induced macrophage polarization and recruitment through cell autophagy and cell exocytosis blocking methods to ultimately control influenza virus infection and acute pneumonia.

[0009] Based on the current status of the prior art, the inventors of the present application intend to provide a method for regulating macrophage polarization, especially a method for regulating macrophage polarization based on the autophagy-exocrine pathway and its use in preparing drugs for treating influenza virus infection. The present invention provides a basis for the development of new anti-influenza virus drugs and antiviral treatment strategies.

[0010] The prior arts related to this application include:

[0011] [1]IWASAKI A,PILLAI PS Innate immunity to influenza virus infection[J]. Nat Rev Immunol. 2014; 14:315-328.

[0012] [2]KRAMMER F,SMITH GJD,FOUCHIER RAM,et al.Influenza[J].Nat RevDis Primers.2018;4:3.

[0013] [3]GUAN Y,VIJAYKRISHNA D,BAHL J,et al.The emergence of pandemicinfluenza viruses[J].Protein&Cell.2010;1:9-13.

[0014] [4]SAUNDERS-HASTINGS P R,KREWSKI D Reviewing the History of PandemicInfluenza:Understanding Patterns of Emergence and Transmission[J].Pathogens.2016;5.

[0015] [5]MANICASSAMY B,MANICASSAMY S,BELICHA-VILLANUEVA A,et al.Analysis ofin vivo dynamics of influenza virus infection in mice using a GFP reportervirus[J].Proc Natl Acad Sci U S A.2010;107:11531-11536.

[0016] [6]TEIJARO J R,WALSH K B,RICE S,et al.Mapping the innate signalingcascade essential for cytokine storm during influenza virus infection[J].ProcNatl Acad Sci U S A.2014;111:3799-3804.

[0017] [7]GEISSMANN F,MANZ M G,JUNG S,et al.Development of monocytes,macrophages,and dendritic cells[J].Science.2010;327:656-661.

[0018] [8]TAIT WOJNO E D,ARTIS D Innate lymphoid cells:balancing immunity,inflammation,and tissue repair in the intestine[J].Cell Host Microbe.2012;12:445-457.

[0019] [9]IWASAKI A,MEDZHITOV R Control of adaptive immunity by the innateimmune system[J].Nat Immunol.2015;16:343-353.

[0020]

[10] GORDON S Alternative activation of macrophages[J].Nat RevImmunol.2003;3:23-35.

[0021]

[11] SHAYKHIEV R,KRAUSE A,SALIT J,et al.Smoking-dependentreprogramming of alveolar macrophage polarization:implication forpathogenesis of chronic obstructive pulmonary disease[J].Journal ofImmunology.2009;183:2867-2883.

[0022]

[12] KASLOFF S B,WEINGARTL H M Swine alveolar macrophage cell modelallows optimal replication of influenza A viruses regardless of their origin[J].Virology.2016;490:91-98.

[0023]

[13] ALENQUER M,AMORIM M J Exosome Biogenesis,Regulation,and Functionin Viral Infection[J].Viruses.2015;7:5066-5083.

[0024]

[14] DESDIN-MICO G,MITTELBRUNN M Role of exosomes in the protection ofcellular homeostasis[J].Cell Adh Migr.2017;11:127-134.

[0025]

[15] YANG Y,LI Y,CHEN X,et al.Exosomal transfer of miR-30a betweencardiomyocytes regulates autophagy after hypoxia[J].J Mol Med(Berl).2016;94:711-724.

[0026]

[16] SHAPOURI-MOGHADDAM A,MOHAMMADIAN S,VAZINI H,et al.Macrophageplasticity,polarization,and function in health and disease[J].Journal ofCellular Physiology.2018;233:6425-6440.

[0027]

[17] LIU Y M,TSENG C H,CHEN Y C,et al.Exosome-delivered and Y RNA-derived small RNA suppresses influenza virus replication[J].J BiomedSci.2019;26:58.

[0028]

[18] YANG Y,HAN Q,HOU Z,et al.Exosomes mediate hepatitis B virus(HBV)transmission and NK-cell dysfunction[J].Cellular&Molecular Immunology.2017;14:465-475.

[0029]

[19] GUO H,CHITIPROLU M,RONCEVIC L,et al.Atg5 Disassociates the V1V0-ATPase to Promote Exosome Production and Tumor Metastasis Independent ofCanonical Macroautophagy[J].Dev Cell.2017;43:716-730.e717.

[0030]

[20] NOWAG H,MUNZ C Diverting autophagic membranes for exocytosis[J].Autophagy.2015;11:425-427.

[0031]

[21] CAROLAN L A,ROCKMAN S,BORG K,et al.Characterization of theLocalized Immune Response in the Respiratory Tract of Ferrets followingInfection with Influenza A and B Viruses[J].J Virol.2015;90:2838-2848.

[0032]

[22] BETAKOVA T,KOSTRABOVA A,LACHOVA V,et al.Cytokines Induced DuringInfluenza Virus Infection[J].Curr Pharm Des.2017;23:2616-2622.

[0033]

[23] COLE S L,DUNNING J,KOK W L,et al.M1-like monocytes are a majorimmunological determinant of severity in previously healthy adults with life-threatening influenza[J].Jci Insight.2017;2:e91868.

[0034]

[24] CHANG P,KUCHIPUDI S V,MELLITS K H,et al.Early apoptosis ofporcine alveolar macrophages limits avian influenza virus replication andpro-inflammatory dysregulation[J].Sci Rep.2015;5:17999.

[0035]

[25] SHORT KR, KROEZE E, FOUCHIER RAM, et al. Pathogenesis ofinfluenza-induced acute respiratory distress syndrome[J].Lancet InfectDis.2014;14:57-69.

[0036]

[26] JULKUNEN I, MELEN K, NYQVIST M, et al. Inflammatory responses ininfluenza A virus infection [J]. Vaccine. 2000; 19Suppl 1: S32-37. Summary of the invention

[0037] The purpose of the present invention is to provide a method for regulating macrophage polarization based on the current state of the prior art, and specifically to provide a method for regulating macrophage polarization based on the autophagy-exocrine pathway and its use.

[0038] The present invention regulates macrophage polarization by using compounds that inhibit cell autophagy and cell exocytosis, and more specifically regulates macrophage polarization function by using a variety of cell autophagy inhibitors and exosome inhibitors, which are further used to prepare drugs for treating influenza virus infection.

[0039] In the present invention, the compound that inhibits cell autophagy includes but is not limited to blockers of various links of cell autophagy, such as one or more of the various structural analogs of PI3K inhibitor LY294002, autophagy lysosome blocker chloroquine CQ, etc.

[0040] In the present invention, the compound that inhibits cell exocytosis includes but is not limited to blockers of various links of cell exocytosis activation, such as one or more of various structural analogs of sphingomyelinase (N-SMase) inhibitor GW4869.

[0041] In the embodiments of the present invention, PI3K inhibition and exosome inhibition can effectively inhibit influenza virus-induced macrophage recruitment and polarization behavior.

[0042] The present invention conducted the following in vitro cell test, and the results showed that:

[0043] (1) In an in vitro cell system infected with influenza virus, autophagy inhibitors and exosome inhibitors had a significant effect on the recruitment of macrophages to influenza virus infection;

[0044] (2) Autophagy inhibitors have a significant effect on influenza virus replication and macrophage polarization;

[0045] The experiments of the present invention confirm that the M1 polarization and recruitment of macrophages can be effectively blocked by cell autophagy inhibitors and exosome inhibitors, providing a basis for further preparation of drugs for treating influenza virus infection.

[0046] In the present invention, the two types of compounds can be used alone or in combination to treat influenza virus without changing the existing drug dosage form, or the above compounds can be made into a dosage form, and its administration route or preparation includes but is not limited to: oral, injection, mucosal administration, injection solution and the like.

[0047] The macrophage polarization regulation function described in the present invention is not directly related to influenza virus infection; the method of the present invention can be used to prepare drugs for treating various influenza virus infections, including but not limited to influenza A virus, influenza B virus, and new influenza virus types.

[0048] The present application provides a method for regulating macrophage polarization, especially a method for regulating macrophage polarization based on the autophagy-exocrine pathway, which can further prepare a drug for treating influenza virus infection. The present invention provides a basis for the development of new anti-influenza virus drugs and antiviral treatment strategies. BRIEF DESCRIPTION OF THE DRAWINGS

[0049] Figure 1 It was shown that PI3K inhibitors and exosome inhibitors inhibited influenza virus-induced macrophage recruitment and cell aggregation.

[0050] Figure 2 Shown are the effects of pan-PI3K inhibitor and PI3Kγ inhibitor on cell polarization and influenza virus replication.

[0051] Figure 3 Shows the effect of specific PI3Kγ inhibitor AS605240 on cellular autophagy and exocytosis.

[0052] Figure 4 It showed that inactive PI3K structural analogs did not affect influenza virus-induced macrophage autophagy and activation.

[0053] The present invention will be further described below in conjunction with specific embodiments. DETAILED DESCRIPTION

[0054] Example 1 PI3K inhibitors and exosome inhibitors inhibit macrophage recruitment and cell aggregation

[0055] The autophagy inhibitor LY294002 (1 μM) and the exosome inhibitor GW4869 (1 μM) were added to the virus-infected Ana-1 macrophages in the lower chamber of the cell transmembrane migration Transwell system, and the effect of GFP on the upper chamber was observed. +Effects on macrophage recruitment (intervention given 24 hours after infection), such as Figure 1 Immunofluorescence analysis as shown shows that viral infection can recruit more GFP + Macrophages; When the autophagy inhibitor LY294002 and the exosome inhibitor GW4869 were used, the results showed that both significantly reduced the expression of GFP + The recruitment of macrophages inhibits the excessive inflammatory response induced by influenza virus.

[0056] Example 2 Effects of pan-PI3K inhibitors and PI3Kγ inhibitors on macrophage polarization

[0057] In this example, the effects of different PI3K inhibitors on the polarization of macrophages infected with influenza virus were compared. Figure 2 As shown, when the pan-PI3K inhibitor LY294002 and the PI3Kγ inhibitor AS605240 were used, the iNOS transcription level was significantly inhibited, the anti-inflammatory IL-10 level was upregulated, and the replication of influenza virus was not significantly reduced. The results showed that the pan-inhibitors consistently downregulated the M1 polarization of macrophages and the transcription of IL-1β.

[0058] Example 3 Effects of PI3K inhibitors on cell autophagy and exocytosis

[0059] This study compared the effects of the PI3Kγ inhibitor AS605240 on macrophage autophagy and exocytosis under infection and non-infection conditions. Figure 3 As shown in the Western blot image, compared with the normal group, after virus infection, the ratio of LC3II / I increased, indicating that cellular autophagy was enhanced; when the specific PI3Kγ inhibitor AS was used, the protein ratio of LC3II / I was significantly reduced, indicating that AS inhibited cellular autophagy caused by influenza virus, and it was dose-dependent; at the same time, the results showed that after influenza virus infection, the levels of exosome CD63 and CD81 proteins were significantly lower than those in the normal group, and when AS was used to block the generation of autophagic LC3, CD63 and CD81 proteins showed a dose-dependent increase. The changes in autophagic protein LC3 and exosome protein CD63 / CD81 suggested the possibility of the existence of autophagic exocytosis. When the generation of autophagic LC3 protein was limited, autophagic exocytosis was also inhibited, resulting in increased intracellular protein accumulation; this process confirmed that influenza virus induced an increase in cellular autophagic protein LC3 and exosome protein CD63, and the phenomenon of autophagic exocytosis existed;

[0060] Further tests were conducted on the effects of the inactive component of the autophagy inhibitor LY303511 hydrochloride on influenza virus-induced macrophage autophagy and pyroptosis protein NLRP3, such as Figure 4As shown, as time went on, influenza virus induced more and more significant macrophage autophagy LC3 accumulation and M1 activation, accompanied by a significant increase in NLRP3, indicating the synchronization of autophagy and pyroptosis; LY303511 hydrochloride did not have a significant effect on the LC3II / I ratio, p62 level, and NLRP3; influenza virus-induced autophagy and pyroptosis in macrophages were affected by active PI3K inhibitory molecules.

[0061] The experiments of the present invention confirm that the M1 polarization and recruitment of macrophages can be effectively blocked by cell autophagy inhibitors and exosome inhibitors, providing a basis for further preparation of drugs for treating influenza virus infection.

Claims

1. A method for regulating macrophage polarization behavior based on the autophagy-exocrine pathway, It is characterized in that The method uses a compound that inhibits cell autophagy to regulate macrophage polarization, which includes: an in vitro cell test on the effect on polarization of macrophages infected with influenza virus; the compound that inhibits cell autophagy is PI3Kγ inhibitor AS605240; the inhibitor AS605240 significantly inhibits iNOS transcription level; The influenza virus is influenza A virus.

2. The method according to claim 1, It is characterized in that Without changing the existing pharmaceutical dosage form, the compound is subjected to the in vitro cell test.